Skip to main navigation Skip to search Skip to main content

Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: Extended 3.5-year follow up from a pooled analysis

  • Simon Rule
  • , Martin Dreyling
  • , Andre Goy
  • , Georg Hess
  • , Rebecca Auer
  • , Brad Kahl
  • , José Ángel Hernández-Rivas
  • , Keqin Qi
  • , Sanjay Deshpande
  • , Lori Parisi
  • , Michael Wang
  • University of Plymouth
  • Ludwig Maximilian University of Munich
  • Johannes Gutenberg University Mainz
  • Queen Mary University of London
  • Washington University St. Louis
  • Hospital Universitario Infanta Leonor
  • Johnson & Johnson
  • University of Texas MD Anderson Cancer Center

Research output: Contribution to journal › Letter › peer-review

163 Scopus citations
Original languageEnglish
Pages (from-to)e211-e214
JournalHaematologica
Volume104
Issue number5
DOIs
StatePublished - 30 Apr 2019

Cite this